FDA Rejects Request to Authorize COVID-19 Treatment
The U.S. Food and Drug Administration (FDA) has rejected a request to authorize a drug as a COVID-19 ...
Source: theepochtimes.com
Page 4 - Mitchell Steiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mitchell Steiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mitchell Steiner Today - Breaking & Trending Today
Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
02.03.2023 - MIAMI, FL, March 02, 2023 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced that the U.S. Food and ... Seite 1
Source: wallstreet-online.de
Veru Inc.: Veru Reports Fiscal 2023 First Quarter Financial Results
Sabizabulin for moderate to severe COVID-19 under review for potential emergency authorization by multiple global regulatory agencies Presented late-breaker oral presentation at IDWeek; sabizabulin treatment
Source: finanznachrichten.de
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bird, Generac, Veru, and Gap and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of
Source: einnews.com
VERU ALERT: Bragar Eagel & Squire, P.C. Reminds Investors
NEW YORK, Dec. 17, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that...
Source: globenewswire.com